MANGOCEUTICALS INC (MGRX) Stock News

USA - NASDAQ:MGRX - US56270V2051 - Common Stock

1.48 USD

+0.29 (+24.37%)

Last: 11/14/2025, 8:02:40 PM

1.41 USD

-0.07 (-4.73%)

After Hours: 11/14/2025, 8:02:40 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MGRX Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill - Mentions: IDN MLSS FTCI LRHC ...

News Image

Unusual volume stocks in Friday's session

4 days ago - By: Chartmill - Mentions: SEE FLY RUBI CMCT ...

News Image

Stay updated with the stocks that are on the move in today's pre-market session.

3 days ago - By: Benzinga - Mentions: LLY NVO PFE MTSR

Ozempic Maker Novo Nordisk Faces Board Shakeup

3 days ago - By: Benzinga - Mentions: XPON IVVD OMER STUB ...

Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

3 days ago - By: Mangoceuticals, Inc.

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

4 days ago - By: Stocktwits - Mentions: LLY NVO

Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs

6 months ago - By: Mangoceuticals, Inc.

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

7 months ago - By: Mangoceuticals, Inc.

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

7 months ago - By: ACCESS Newswire

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions

7 months ago - By: ACCESS Newswire

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

8 months ago - By: Mangoceuticals, Inc.

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

9 months ago - By: Mangoceuticals, Inc.

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

10 months ago - By: Mangoceuticals, Inc.

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

a year ago - By: Mangoceuticals, Inc.

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

a year ago - By: Mangoceuticals, Inc.

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

a year ago - By: Mangoceuticals, Inc.

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

a year ago - By: Mangoceuticals, Inc.

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

a year ago - By: Mangoceuticals, Inc.

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

a year ago - By: Mangoceuticals, Inc.

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment